what myeloma patients need to know about bispecific antibodies
Published 1 year ago • 35 plays • Length 5:58Download video MP4
Download video MP3
Similar videos
-
1:52
how is bispecific antibody therapy changing myeloma care?
-
1:55
bispecific antibodies for myeloma | patient eligibility requirements
-
3:25
what should myeloma patients know about bispecific antibodies?
-
25:45
care partners | what should you know about the bispecific antibody treatment for myeloma?
-
4:09
what myeloma patients should know about treatment monitoring
-
7:15
evolving myeloma treatment options | bispecific antibody therapy
-
2:16
what is the role of bispecific antibody therapies in future myeloma care?
-
0:53
what do myeloma patients need to know about immune based therapies
-
9:34
targeting of myeloma disease progression and bispecific antibody advantages
-
32:26
what should you know about emerging myeloma treatment options?
-
31:04
thriving with myeloma: what you should know about care and treatment
-
7:18
what should patients know about myeloma testing?
-
2:33
bispecific antibody therapy support | care team members and resources
-
1:33
how has bispecific antibody therapy impacted myeloma care?
-
4:02
what’s the latest in emerging myeloma research?
-
6:37
understanding myeloma testing and monitoring | an overview
-
4:54
bispecific antibody therapy | managing side effects
-
5:45
understanding myeloma treatment types
-
8:45
myeloma expert gives an overview of novel therapies